Signaturefd, LLC Crispr Therapeutics Ag Transaction History

Signaturefd, LLC

$4.94 Billion
Q1 2025

A detailed history of Signaturefd, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Signaturefd, LLC holds 1,675 shares of CRSP stock, worth $62,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,675

Previous 1,757 4.67%

Holding current value

$62,929

Previous $69,000 17.39%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$34.03 - $53.02 $2,790 - $4,347	-82 Reduced 4.67%	1,675 $57,000
Q4 2024 Feb 10, 2025	SELL	$38.65 - $55.15 $6,184 - $8,824	-160 Reduced 8.35%	1,757 $69,000
Q3 2024 Oct 21, 2024	SELL	$44.62 - $62.75 $1,249 - $1,757	-28 Reduced 1.44%	1,917 $90,000
Q2 2024 Jul 29, 2024	SELL	$51.17 - $68.18 $767 - $1,022	-15 Reduced 0.77%	1,945 $105,000
Q1 2024 May 03, 2024	BUY	$60.67 - $89.12 $3,518 - $5,168	58 Added 3.05%	1,960 $133,000
Q4 2023 Jan 31, 2024	SELL	$38.62 - $72.18 $8,573 - $16,023	-222 Reduced 10.45%	1,902 $119,000
Q3 2023 Nov 03, 2023	BUY	$45.39 - $59.0 $10,712 - $13,924	236 Added 12.5%	2,124 $96,000
Q2 2023 Aug 01, 2023	SELL	$43.47 - $67.77 $738 - $1,152	-17 Reduced 0.89%	1,888 $105,000
Q1 2023 Apr 28, 2023	BUY	$41.0 - $56.12 $10,004 - $13,693	244 Added 14.69%	1,905 $86,000
Q4 2022 Jan 27, 2023	SELL	$39.19 - $65.67 $14,265 - $23,903	-364 Reduced 17.98%	1,661 $67,000
Q3 2022 Nov 08, 2022	BUY	$61.1 - $83.78 $15,458 - $21,196	253 Added 14.28%	2,025 $132,000
Q2 2022 Aug 10, 2022	SELL	$43.23 - $73.83 $1,599 - $2,731	-37 Reduced 2.05%	1,772 $108,000
Q1 2022 May 02, 2022	BUY	$53.19 - $79.24 $56,860 - $84,707	1,069 Added 144.46%	1,809 $114,000
Q4 2021 Jan 25, 2022	SELL	$70.09 - $111.29 $13,667 - $21,701	-195 Reduced 20.86%	740 $56,000
Q3 2021 Oct 28, 2021	SELL	$110.2 - $156.64 $158,137 - $224,778	-1,435 Reduced 60.55%	935 $105,000
Q2 2021 Jul 26, 2021	SELL	$100.84 - $161.89 $9,075 - $14,570	-90 Reduced 3.66%	2,370 $384,000
Q1 2021 Apr 30, 2021	BUY	$110.72 - $210.04 $171,062 - $324,511	1,545 Added 168.85%	2,460 $300,000
Q4 2020 Feb 11, 2021	BUY	$79.67 - $173.23 $9,162 - $19,921	115 Added 14.37%	915 $140,000
Q3 2020 Nov 03, 2020	SELL	$78.5 - $100.64 $5,102 - $6,541	-65 Reduced 7.51%	800 $67,000
Q2 2020 Jul 30, 2020	SELL	$38.5 - $76.05 $2,887 - $5,703	-75 Reduced 7.98%	865 $64,000
Q1 2020 Apr 23, 2020	BUY	$33.68 - $62.53 $9,262 - $17,195	275 Added 41.35%	940 $40,000
Q2 2019 Jul 31, 2019	SELL	$35.45 - $48.2 $709 - $964	-20 Reduced 2.92%	665 $31,000
Q1 2019 May 09, 2019	BUY	$28.02 - $40.87 $2,381 - $3,473	85 Added 14.17%	685 $24,000
Q4 2018 Feb 13, 2019	SELL	$22.73 - $42.34 $38,641 - $71,978	-1,700 Reduced 73.91%	600 $17,000
Q3 2018 Nov 15, 2018	SELL	$44.35 - $65.71 $2,217 - $3,285	-50 Reduced 2.13%	2,300 $102,000
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $55,406 - $95,667	1,300 Added 123.81%	2,350 $138,000
Q1 2018 May 08, 2018	BUY	$23.52 - $58.17 $24,696 - $61,078	1,050 New	1,050 $48,000

Others Institutions Holding CRSP

# of Institutions

479

Shares Held

64.2M

Call Options Held

2.15M

Put Options Held

1.92M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $2.93B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account